The European dental bone graft substitute (DBGS) market valuation was €319.3 million in 2022. Due to several driving factors including the dental implant market, aging demographics, and the growing acceptance of allograft materials – the European DBGS market is predicted to surpass €411.6 million by 2029. Let’s explore some of the trends and factors propelling the DBSG market in Europe.
WHICH SEGMENTS ARE INCLUDED WITHIN THE EUROPEAN DENTAL BONE GRAFT SUBSTITUTE ANALYSIS?
The European market for DBGSs and other biomaterials includes DBGSs, dental growth factors, dental barrier membranes (DBMs), local antimicrobial periodontal treatment and dental soft tissue regeneration.
WHICH FACTORS ARE DRIVING GROWTH OVER THE NEXT 7 YEARS?
Within the European dental bone graft substitute market, a multitude of factors are at play and are pushing the market towards reaching €411.6 million by 2029.
1. Demographic Factors
The demand for dental implants and corresponding dental grafting procedure will increase with the growing elderly demographic, as older patients tend to have more missing teeth than younger patients. In addition, elderly people are more likely to suffer not only from tooth loss but also from poor bone quality, which necessitates a bone grafting procedure prior to the implant treatment. Moreover, some countries in Europe include dental implant and sometimes DBGS coverage for those over age 65.
2. Growing Acceptance of Allograft Materials
In the past, the risk of disease transmission was strongly associated with allograft and xenograft materials. However, technological advancement and adoption of more stringent quality assurance and traceability requirements have provided a certain level of safety. With these efforts, both dental professionals and patients are now more comfortable accepting an allograft product. Additionally, allograft manufacturers have been able to successfully meet the necessary requirements to gain licensed approvals.
3. Growth of the Dental Implant Market
The dental implant market is demonstrating growth across Europe, especially in relatively underdeveloped implant markets. As bone graft procedures are performed for approximately one-third of the dental implant procedures, growth of the dental implant market is set to continue to generate growth for the DBGS market. The global penetration of DBGS materials into dental implantation procedures was estimated at nearly 50%. This indicates a great potential to further growth of the European DBGS market, combined with sustained demand for dental implant procedures in an aging European population.
4. Accumulation of Clinical Evidence
Scientific articles and studies play a crucial role in gaining acceptance for DBGS products, particularly synthetic and allograft variants, which may be less familiar to medical practitioners compared to autografts or xenografts. While company-conducted studies before product approval are valuable, larger and longer-term studies carry more persuasive weight. Demonstrating successful outcomes over an extended period will bolster the acceptance of synthetic, allograft, and extensively processed DBGSs. This, in turn, will elevate the significance of the DBGS market by promoting their use instead of autografts, potentially reducing the required volume of autografts per procedure.
Grafting materials are widely utilized in various medical specialties, including dental, orthopedic, and cardiovascular fields, among others. Allografts have emerged as a viable alternative to autografts in several specialties. For instance, the use of allografts in orthopedic surgeries has seen a significant increase of slightly over 74% between 2008 and 2018. DBM allografts find application in diverse procedures such as maxillofacial surgery, spinal fusion, long bone fracture treatment, foot and ankle fusion, tumor surgeries, and more. The cumulative clinical evidence from multiple specialties can profoundly influence the wider adoption of allografts in dental applications.
Among several others.
WHAT COMPANIES ARE COMPETING IN THE OVERALL MARKET?
Geistlich, botiss biomaterials, and ZimVie are the top three leading companies in the market. In 2022, Geistlich held the dominant position in the total European DBGS and other biomaterials market, primarily due to its strong presence in the DBGS and dental barrier membrane segments. Geistlich’s remarkable share in the DBGS market is mainly attributed to its leadership in the xenograft segment, where it accounted for over 50% of the market value.
However, the market dynamics are changing rapidly due to various merger and acquisition activities carried out by different companies throughout 2022 and into 2023. These actions are likely to influence the market share over the next decade.
In May 2022, Straumann Group acquired PlusDental, a provider of doctor-led, clear aligner treatment solutions, enabling Straumann to expand its operations in the Netherlands, Sweden, and the United Kingdom. Subsequently, in April and July 2022, Envista made significant acquisitions, taking over Carestream Dental’s Intraoral Scanner Business and acquiring all equity of Osteogenic Biomedical, Allotech LLC, and OBI Biologics, respectively.
In July 2022, Geistlich acquired Lynch Biologics and integrated the company into its existing USA affiliate. Henry Schein also joined the acquisition trend, purchasing Midway Dental Supply in August 2022 and Biotech Dental S.A.S in December 2022.
Continuing this trend, in May 2023, Straumann Group acquired GalvoSurge Dental AG, focusing on expanding their expertise in implantology with a new peri-implantitis treatment solution.
With numerous acquisitions happening among various companies outside the current top three market leaders, competition is expected to intensify throughout 2029. Companies are actively strengthening their portfolios and advancing their offerings to secure a competitive edge in the evolving market landscape.
Learn More
To gain even more insights into the European Dental Bone Graft Substitute Market, and to further explore market trends, key market players, and some of the factors limiting the overall market growth – click on the button below to receive a complimentary executive summary.
